IL50274A - Oral pharmaceutical preparations with anabolic activity comprising esters of nandrolone - Google Patents
Oral pharmaceutical preparations with anabolic activity comprising esters of nandroloneInfo
- Publication number
- IL50274A IL50274A IL50274A IL5027476A IL50274A IL 50274 A IL50274 A IL 50274A IL 50274 A IL50274 A IL 50274A IL 5027476 A IL5027476 A IL 5027476A IL 50274 A IL50274 A IL 50274A
- Authority
- IL
- Israel
- Prior art keywords
- nandrolone
- esters
- pharmaceutical preparations
- oral pharmaceutical
- anabolic activity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7510104A NL7510104A (nl) | 1975-08-27 | 1975-08-27 | Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat. |
Publications (2)
Publication Number | Publication Date |
---|---|
IL50274A0 IL50274A0 (en) | 1976-10-31 |
IL50274A true IL50274A (en) | 1980-11-30 |
Family
ID=19824362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL50274A IL50274A (en) | 1975-08-27 | 1976-08-16 | Oral pharmaceutical preparations with anabolic activity comprising esters of nandrolone |
Country Status (17)
Country | Link |
---|---|
US (1) | US4083973A (el) |
JP (1) | JPS5231063A (el) |
AU (1) | AU508727B2 (el) |
BE (1) | BE845613A (el) |
CA (1) | CA1092025A (el) |
DE (1) | DE2638507A1 (el) |
FR (1) | FR2321892A1 (el) |
GB (1) | GB1563302A (el) |
GR (1) | GR70296B (el) |
HU (1) | HU176743B (el) |
IE (1) | IE44533B1 (el) |
IL (1) | IL50274A (el) |
LU (1) | LU75648A1 (el) |
NL (1) | NL7510104A (el) |
NZ (1) | NZ181865A (el) |
PH (1) | PH12363A (el) |
ZA (1) | ZA764868B (el) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT358530B (de) * | 1978-04-25 | 1980-09-10 | Plc Pharma Licences | Stabilisierungsverfahren |
NL7806048A (nl) * | 1978-06-02 | 1979-12-04 | Kali Chemie Pharma Gmbh | Geneesmiddel met betere resorptie-eigenschappen en werkwijze voor de bereiding daarvan. |
EP0177342A3 (en) * | 1984-10-04 | 1987-12-02 | Genentech, Inc. | Oral formulation of therapeutic proteins |
US5140021A (en) * | 1986-04-16 | 1992-08-18 | Genesis Systems Corporation | Method and dosage form for treatment of premenstrual syndrome |
US5208032A (en) * | 1988-07-15 | 1993-05-04 | Rutgers, The State University Of New Jersey | Increasing the growth of turkeys using implant of 19-nortestosterone |
AU696855B2 (en) * | 1994-03-18 | 1998-09-17 | Shire Laboratories, Inc. | Emulsified drug delivery systems |
US5824638A (en) * | 1995-05-22 | 1998-10-20 | Shire Laboratories, Inc. | Oral insulin delivery |
US6011027A (en) * | 1999-02-18 | 2000-01-04 | Lpj Research, Inc. | Use of 19-nor-4-androstenediol to increase 19-nortestosterone levels in humans |
US6652880B1 (en) | 1999-04-01 | 2003-11-25 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
AU2003231126A1 (en) | 2002-04-25 | 2003-11-10 | Banner Pharmacaps, Inc. | Chewable soft capsule |
GB0304927D0 (en) * | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
EP1530965B1 (en) | 2003-11-11 | 2006-03-08 | Mattern, Udo | Controlled release delivery system of sexual hormones for nasal application |
CN1257711C (zh) * | 2003-12-05 | 2006-05-31 | 石药集团中奇制药技术(石家庄)有限公司 | 丁苯酞软胶囊及其制备工艺 |
US20060140820A1 (en) | 2004-12-28 | 2006-06-29 | Udo Mattern | Use of a container of an inorganic additive containing plastic material |
US20070088012A1 (en) * | 2005-04-08 | 2007-04-19 | Woun Seo | Method of treating or preventing type-2 diabetes |
EP1937276B1 (en) | 2005-10-12 | 2012-11-21 | Unimed Pharmaceuticals, LLC | Improved testosterone gel and method of use |
PT2068825E (pt) | 2006-10-04 | 2011-02-11 | M & P Patent Ag | Sistema de administração de libertação controlada para aplicação nasal de neurotransmissores |
US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
KR20170020779A (ko) | 2014-06-17 | 2017-02-24 | 머크 샤프 앤 도메 비.브이. | 테스토스테론 운데카노에이트의 안정한 제제 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2998423A (en) * | 1958-02-25 | 1961-08-29 | Organon | Esters of 19-nortestosterone |
US3016388A (en) * | 1959-06-30 | 1962-01-09 | Organon | New esters of 19-nor-testosterone |
US3400197A (en) * | 1965-01-26 | 1968-09-03 | Robins Co Inc A H | Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules |
NL189235C (nl) * | 1974-02-28 | 1993-02-16 | Akzo Nv | Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking. |
-
1975
- 1975-08-27 NL NL7510104A patent/NL7510104A/xx not_active Application Discontinuation
-
1976
- 1976-08-11 IE IE1778/76A patent/IE44533B1/en unknown
- 1976-08-12 ZA ZA764868A patent/ZA764868B/xx unknown
- 1976-08-16 US US05/714,454 patent/US4083973A/en not_active Expired - Lifetime
- 1976-08-16 IL IL50274A patent/IL50274A/xx unknown
- 1976-08-17 GB GB34253/76A patent/GB1563302A/en not_active Expired
- 1976-08-19 AU AU16980/76A patent/AU508727B2/en not_active Expired
- 1976-08-24 JP JP51101474A patent/JPS5231063A/ja active Pending
- 1976-08-24 HU HU76AO441A patent/HU176743B/hu unknown
- 1976-08-24 LU LU75648A patent/LU75648A1/xx unknown
- 1976-08-25 GR GR51544A patent/GR70296B/el unknown
- 1976-08-26 FR FR7625795A patent/FR2321892A1/fr active Granted
- 1976-08-26 CA CA259,950A patent/CA1092025A/en not_active Expired
- 1976-08-26 NZ NZ181865A patent/NZ181865A/xx unknown
- 1976-08-26 DE DE19762638507 patent/DE2638507A1/de not_active Withdrawn
- 1976-08-27 PH PH7618840A patent/PH12363A/en unknown
- 1976-08-27 BE BE170156A patent/BE845613A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PH12363A (en) | 1979-01-29 |
GB1563302A (en) | 1980-03-26 |
DE2638507A1 (de) | 1977-03-03 |
IE44533B1 (en) | 1981-12-30 |
BE845613A (fr) | 1977-02-28 |
IL50274A0 (en) | 1976-10-31 |
FR2321892B1 (el) | 1979-05-25 |
NZ181865A (en) | 1978-12-18 |
FR2321892A1 (fr) | 1977-03-25 |
CA1092025A (en) | 1980-12-23 |
LU75648A1 (el) | 1977-03-31 |
ZA764868B (en) | 1977-07-27 |
AU508727B2 (en) | 1980-04-03 |
AU1698076A (en) | 1978-02-23 |
IE44533L (en) | 1977-02-27 |
US4083973A (en) | 1978-04-11 |
HU176743B (en) | 1981-05-28 |
JPS5231063A (en) | 1977-03-09 |
GR70296B (el) | 1982-09-06 |
NL7510104A (nl) | 1977-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL50274A (en) | Oral pharmaceutical preparations with anabolic activity comprising esters of nandrolone | |
ZA761118B (en) | 1,4-dihydropyridine-carboxylic acid aralkyl esters,processes for their preparations and their use as medicaments | |
IL49640A0 (en) | Estradiol esters and oral estrogenic preparations containing them | |
PH13807A (en) | Oral pharmaceutical preparation of esters testasterone | |
MY7900169A (en) | Production of long acting insulin preparations | |
JPS5227764A (en) | Heteroarylbenzocacepinee acetic acid * precursor and derivatives thereof | |
ZA751102B (en) | Pharmaceutical preparations | |
JPS52142060A (en) | Prostaglandin derivative its preparation and medicine containing same | |
JPS5236637A (en) | Phenoxy alkyl carboxylic acid derivatives *process for preparing the same and pharmaceutical containing the same having lipidddepleting activity | |
JPS5273885A (en) | Benzopyron derivative and its production and drugs having antiiallergy effect containing same | |
NZ182046A (en) | 9-0-ethers of clavulanic acid,saltd and esters and pharmaceutical compositions | |
IL45014A0 (en) | An isobutyric acid derivative and therapeutic compositions containing it | |
FR2335231A1 (fr) | Esters steroidiques a effet retard et medicaments qui en contiennent | |
NZ179683A (en) | Pharmaceutical compositions comprising certain cyclopropane carboxylates | |
IL50285A0 (en) | Vinylthionophosphoric acid esters their preparation and their use as insecticides and acaricides | |
IL47401A0 (en) | Herbicidal preparations containing a phenoxyalkanoic acid derivative and a carbamic acid ester | |
NZ181107A (en) | 16-hydroxycarbyloxy-16-deacet-oxyfusidic acid derivatives and analogs thereof | |
GB1521822A (en) | Preparation of formate esters | |
IL50186A (en) | O-pyridazinone esters of alkanethiophosphonic acid and of their dithioanalogues their preparation and their use as insecticides and acaricides | |
JPS51122008A (en) | Dimercaptoethylether derivative preparation method and medicine containing same | |
JPS53121743A (en) | Derivative of prosten acid and preparation thereof | |
AU8487175A (en) | Pharmaceutical preparations | |
JPS523060A (en) | Paraachlorophenoxyisobutyric acid derivatives and preparation thereof | |
JPS5215813A (en) | Preparation of stable medicine including homopyrimidazole derivative for aural administration | |
JPS5276416A (en) | Preparation of medical material with antiaggulutinating activity |